The FDA has rejected a radiopharmaceutical therapy because of manufacturing issues, halting what would have been a competitor for Novartis.

Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...

Sanofi is experiencing shortages of two medicines used to treat Pompe disease, and the problem emerged shortly after the Food ...

RFK Jr. is claiming a win with a new proposal on the food industry's GRAS loophole; nutrition advocates give mixed reviews.

Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new hurdles.

Kuppalli is an infectious diseases physician and former WHO medical officer. She served as medical director of an Ebola treatment unit in Sierra Leone during the 2014–2016 West Africa Ebola epidemic.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Sionna Therapeutics said Monday that its ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. An experimental medicine from Silence ...

The NIH plans to close the door on one of the few pathways available to international students on visas to forge a career in ...

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.